Recital 3, Regulation (EU) 2018/2005

In force

On 1 April 2016, the Agency, in cooperation with Denmark, submitted an Annex XV dossier for the four phthalates [https://echa.europa.eu/previous-consultations-on-restriction-proposals/-/substance-rev/13919/term]. The dossier built on a previous restriction proposal submitted by Denmark in 2011 in relation to which the Agency's Risk Assessment Committee (RAC) and Socio-Economic Analysis Committee (SEAC) adopted opinions [2012 RAC and SEAC Opinion on an Annex XV dossier proposing restrictions on the four phthalates: https://echa.europa.eu/documents/10162/58050be8-f7be-4b55-b106-76dda4989dd6] based on which the Commission decided not to amend Annex XVII to Regulation (EC) No 1907/2006 [Commission Communication 2014/C 260/01.] on the grounds that the data available at the time did not indicate that combined exposure to the four phthalates presented a risk. The 2016 Annex XV dossier took into account new information on exposure from different sources including human biomonitoring data from the Union-wide DEMOCOPHES project [http://www.eu-hbm.info/democophes/project-partners] which measures the presence of the four phthalates in urine samples.